TL;DR
This study investigates how different MRI sequences, when fused with CT scans, improve the accuracy and consistency of defining the "tumor bed" (the area where a tumor was removed) in breast cancer patients undergoing radiotherapy. The findings suggest that specific MRI sequences, particularly sdyn-eTHRIVE, significantly reduce variations between different doctors' delineations, leading to more precise treatment planning and potentially smaller radiation volumes.
What Problem Does This Paper Address?
Accurately defining the tumor bed (TB) after breast-conserving surgery (BCS) is crucial for effective radiotherapy. The TB is the target volume that needs to be irradiated to eliminate any remaining cancer cells and reduce the risk of local recurrence. However, delineating this area can be challenging due to factors like the presence of seroma (fluid collection), clips used during surgery, and the inherent variability in how different clinicians interpret medical images. Traditional methods using only computed tomography (CT) scans have shown limitations in precisely defining the TB, leading to inconsistencies in treatment planning. This paper aims to address this by exploring how preoperative magnetic resonance imaging (pre-MRI), fused with postoperative CT (post-CT), can improve the accuracy and reduce inter-observer variability in TB delineation compared to using post-CT alone.
Methods
The researchers analyzed pre-MRI and post-CT scans from 10 breast cancer patients who had undergone BCS and were scheduled for radiotherapy. The pre-MRI scans were acquired using six different sequences: T1, T2, T2W-SPAIR, DWI, dyn-eTHRIVE, and sdyn-eTHRIVE. These pre-MRI scans were then fused with the post-CT scans, which were taken in the same prone position.
Five expert observers (three radiation oncologists and two radiologists) were tasked with delineating the clinical target volume (CTV) and planning target volume (PTV). For CT-based delineation, they used post-CT scans. For MRI-based delineation, they used the fused pre-MRI and post-CT images. The gross tumor volume (GTV) from pre-MRI was expanded by 10mm to form the CTV-pre-MRI, and then further expanded by 15mm to create the PTV-pre-MRI, with specific restrictions to avoid skin and chest wall interfaces.
The study evaluated inter-observer variability using three metrics: mean volume, conformity index (CI), and Dice coefficient (DC). These metrics help quantify how consistently the observers agreed on the size and shape of the delineated volumes.
Datasets
The study utilized imaging data from 10 patients who underwent lumpectomy and lymph node dissection for invasive ductal carcinoma. These patients were scheduled for adjuvant radiotherapy. The data included preoperative MRI scans (acquired using six different sequences) and postoperative CT scans. No new benchmark datasets were introduced; the study used existing patient data for its analysis.
Key Insights and Ideas
- MRI Fusion is Key: Combining pre-MRI with post-CT significantly improves the definition of the tumor bed compared to CT alone.
- Reduced Variability is Crucial: The primary benefit of MRI fusion lies in reducing the differences in how multiple doctors delineate the target volume. This consistency is vital for accurate and reproducible treatment.
- Specific MRI Sequences Shine: Not all MRI sequences are created equal for this task. The
sdyn-eTHRIVEsequence, in particular, demonstrated superior performance in terms of observer agreement. - Smaller Treatment Volumes: By providing a more precise definition of the tumor bed, MRI fusion can lead to smaller target volumes, potentially reducing radiation exposure to healthy tissues and minimizing side effects.
Key Results
- Smaller Volumes with MRI: Mean volumes for both CTV and PTV were consistently smaller when delineated using pre-MRI fused with post-CT compared to CT-based delineation alone.
- Improved Observer Consistency: The Dice coefficient (DC) and Conformity Index (CI) were generally higher for MRI-based delineations across all sequences, indicating better agreement among observers.
sdyn-eTHRIVEStands Out: Thesdyn-eTHRIVEsequence showed the lowest inter-observer variability, with the highest DC values for both CTV and PTV. For PTV, the DC was 0.93 withsdyn-eTHRIVE, compared to 0.79 for CT.- Significant Volume Reduction: Target volume reduction percentages were notable, with PTV volumes reduced by up to 30% when using pre-MRI sequences compared to CT.
Limitations and Future Work
The authors acknowledge several limitations:
- Small Sample Size: The study included only 10 patients, which limits the generalizability of the findings.
- Unclear True Tumor Volume: The exact true tumor volume and its extended margin were not precisely defined by pathological confirmation, making it difficult to definitively assess MRI's over- or underestimation.
- Registration Challenges: Rigid registration between pre-MRI and post-CT datasets can be affected by the non-rigid nature of breast shape changes over time, potentially leading to inconsistencies. Deformable image registration (DIR) is suggested as a potential future tool, though its reliability for multimodality imaging is noted as a challenge.
- Variability in Clinical Factors: Factors like infection after surgery or individual differences in how clinicians interpret images (even with guidelines) can still contribute to variability.
Future work could focus on larger, multi-center studies to validate these findings. Further research into optimizing registration techniques and developing standardized protocols for MRI-based TB delineation would also be beneficial. The study suggests that sdyn-eTHRIVE is a promising sequence for improving the accuracy and consistency of TB delineation in breast cancer radiotherapy.
Summary updated